4.4 Article

Are clinical trials for insomnia recruiting real-world patients?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials

Emmanuel Mignot et al.

Summary: This study assessed the safety and efficacy of daridorexant, a novel orexin receptor antagonist, in improving nighttime and daytime symptoms of insomnia. The results showed that daridorexant improved sleep outcomes and daytime functioning, with a favorable safety profile.

LANCET NEUROLOGY (2022)

Article Psychology, Clinical

The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice

R. van der Lem et al.

PSYCHOLOGICAL MEDICINE (2011)